BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 791328)

  • 1. Haemodynamic effects of long-term oral labetalol.
    Edwards RC; Raftery EB
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
    Koch G
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential haemodynamic effects of labetalol at rest and during exercise in essential hypertension.
    Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
    Postgrad Med J; 1980; 56 Suppl 2():21-6. PubMed ID: 7433338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent.
    Joekes AM; Thompson FD
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):789-93. PubMed ID: 990156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular dynamics after acute and long-term alpha- and beta-adrenoceptor blockade at rest, supine and standing, and during exercise.
    Koch G
    Br J Clin Pharmacol; 1979; 8(Suppl 2):101S-105S. PubMed ID: 43162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise.
    Koch G
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):729-32. PubMed ID: 10951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of labetalol during halothane anaesthesia.
    Scott DB; Buckley FP; Drummond GB; Littlewoods DG; Macrae WR
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):817-21. PubMed ID: 990159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in rest and exercise hemodynamics during long term therapy with a combination alpha and beta blocker in essential hypertension].
    Koch G
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():219-20. PubMed ID: 349925
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
    Ronne-Rasmussen JO; Andersen GS; Jensen NB; Andersson E
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):805-8. PubMed ID: 990157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulatory effects of noradrenaline and adrenaline before and after labetalol.
    Richards DA; Prichard BN; Hernández R
    Br J Clin Pharmacol; 1979 Apr; 7(4):371-8. PubMed ID: 444356
    [No Abstract]   [Full Text] [Related]  

  • 11. Immediate effects of labetalol on central, splanchnic-hepatic, and forearm haemodynamics during pleasant emotional stress in hypertensive patients.
    Trap-Jensen J; Clausen JP; Hartling OJ; Svendsen TL; Krogsgaard AR
    Postgrad Med J; 1980; 56 Suppl 2():37-42. PubMed ID: 7433341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of exercise on intra-arterial blood pressure and pulse rate before and during long-term high-dose treatment with labetalol in patients with severe, therapy-resistant hypertension.
    la Cour Petersen E; Kristensen BO
    Postgrad Med J; 1980; 56 Suppl 2():60-4. PubMed ID: 7433345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hemodynamic effects of labetalol in severe hypertension.
    Omvik P; Lund-Johansen P
    J Cardiovasc Pharmacol; 1982; 4(6):915-20. PubMed ID: 6185782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockade in ischaemic heart disease--influence of concomitant ISA or alpha-blockade on haemodynamic profile.
    Silke B; Nelson GI; Ahuja RC; Taylor SH
    Postgrad Med J; 1983; 59 Suppl 3():45-52. PubMed ID: 6359109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous labetalol in hypertensive patients treated with beta-adrenoreceptor-blocking drugs.
    Pearson RM; Havard CW
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):795-8. PubMed ID: 10953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiovascular effects of acute administration of labetalol in hypertensive patients].
    Novo S; Pinto A; Davì G; Riolo F; Gullotti D
    Boll Soc Ital Cardiol; 1980; 25(2):149-56. PubMed ID: 7016144
    [No Abstract]   [Full Text] [Related]  

  • 17. Double-blind trial of labetalol.
    Kane J; Gregg I; Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.
    Trust PM; Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):799-803. PubMed ID: 791333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension.
    Lund-Johansen P; Bakke OM
    Br J Clin Pharmacol; 1979 Feb; 7(2):169-74. PubMed ID: 760749
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of combined alpha and beta blockade with labetalol on the haemodynamics of stress reaction in hypertensives (author's transl)].
    Bahlmann J; Brod J; Hubrich W; Pretschner P
    Dtsch Med Wochenschr; 1980 Oct; 105(41):1414-8. PubMed ID: 7449643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.